Here is How A lot You Would Have Made Proudly owning Regeneron Prescription drugs Inventory In The Final 15 Years – Regeneron Prescription drugs (NASDAQ:REGN)

Regeneron Prescription drugs REGN has outperformed the market over the previous 15 years by 9.69% on an annualized foundation producing a mean annual return of 21.89%. At present, Regeneron Prescription drugs has a market capitalization of $52.77 billion.

Shopping for $100 In REGN: If an investor had purchased $100 of REGN inventory 15 years in the past, it will be value $1,840.98 as we speak primarily based on a value of $488.79 for REGN on the time of writing.

Regeneron Prescription drugs’s Efficiency Over Final 15 Years

Lastly — what is the level of all this? The important thing perception to take from this text is to notice how a lot of a distinction compounded returns could make in your money development over a time frame.

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.